Author

Rahul P

Dr. Reddy's Laboratories Ltd - Cited by 1,090 - Computer Aided Drug Design - PK modeling - Software Development

Biography

Rahul P currently working in the Department of Community Medicine. His research interests includes Hepatic and Gastric complications. He has authored of many research articles/books related to Radiology. He has successfully completed his Administrative responsibilities.
Title
Cited by
Year
Oral delivery of anticancer drugs: challenges and opportunities
K Thanki, RP Gangwal, AT Sangamwar, S JainJournal of controlled release 170 (1), 15-40, 2013201
468
2013
3D QSAR pharmacophore-based virtual screening and molecular docking studies to identify novel matrix metalloproteinase 12 inhibitors
U Singh, RP Gangwal, GV Dhoke, R Prajapati, AT SangamwarMolecular Simulation 39 (5), 385-396, 201288201
88
2012
A PPAR-β/δ agonist is neuroprotective and decreases cognitive impairment in a rodent model of Parkinson’s disease
N R Das, R P Gangwal, M V Damre, A T Sangamwar, S S SharmaCurrent neurovascular research 11 (2), 114-124, 2014201
48
2014
Oleanolic acid analogs as NO, TNF-α and IL-1β inhibitors: Synthesis, biological evaluation and docking studies
P Bhandari, NK Patel, RP Gangwal, AT Sangamwar, KK BhutaniBioorganic & Medicinal Chemistry Letters 24 (17), 4114-4119, 2014201
40
2014
A combined ligand and structure based approach to design potent PPAR-alpha agonists
GV Dhoke, RP Gangwal, AT SangamwarJournal of Molecular Structure, 2012201
29
2012
p38 Mitogen-activated protein kinase inhibitors: a review on pharmacophore mapping and QSAR studies
RP Gangwal, A Bhadauriya, MV Damre, GV Dhoke, AT SangamwarCurrent topics in medicinal chemistry 13 (9), 1015-1035, 2013201
28
2013
Synthesis, biological evaluation and 3D QSAR study of 2, 4-disubstituted quinolines as anti-tuberculosis agents
SR Patel, R Gangwal, AT Sangamwar, R JainEuropean journal of medicinal chemistry 93, 511-522, 2015201
27
2015
Characterization of degradation products of Ivabradine by LC‐HR‐MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid …
PN Patel, RM Borkar, PD Kalariya, RP Gangwal, AT Sangamwar, ...Journal of Mass Spectrometry 50 (2), 344-353, 2015201
26
2015
22
2013
Identification of p38α MAP kinase inhibitors by pharmacophore based virtual screening
RP Gangwal, NR Das, K Thanki, MV Damre, GV Dhoke, SS Sharma, ...Journal of Molecular Graphics and Modelling 49, 18-24, 2014201
21
2014
Structure based virtual screening to identify selective phosphodiesterase 4B inhibitors
RP Gangwal, MV Damre, NR Das, GV Dhoke, A Bhadauriya, RA Varikoti, ...Journal of Molecular Graphics and Modelling 57, 89-98, 2015201
17
2015
2′-Hydroxy flavanone derivatives as an inhibitors of pro-inflammatory mediators: Experimental and molecular docking studies
NK Patel, K Bairwa, R Gangwal, G Jaiswal, SM Jachak, AT Sangamwar, ...Bioorganic & Medicinal Chemistry Letters 25 (9), 1952-1955, 2015201
16
2015
3D-QSAR and Molecular Docking Analysis of (4-Piperidinyl)-Piperazines as Acetyl-CoA Carboxylases Inhibitors
U Singh, RP Gangwal, GV Dhoke, R Prajapati, M Damre, AT SangamwarArabian Journal of Chemistry, 2012201
15
2012
3D-QSAR and molecular docking studies of amino-pyrimidine derivatives as PknB inhibitors
MV Damre, RP Gangwal, GV Dhoke, M Lalit, D Sharma, K Khandelwal, ...Journal of the Taiwan Institute of Chemical Engineers 45 (2), 354-364, 2014201
15
2014
Effect of different “states” of sorbed water on amorphous celecoxib
G Shete, S Kuncham, V Puri, RP Gangwal, AT Sangamwar, AK BansalJournal of pharmaceutical sciences 103 (7), 2033-2041, 2014201
12
2014
LINCRNA00273 promotes cancer metastasis and its G-Quadruplex promoter can serve as a novel target to inhibit cancer invasiveness
S Jana, J Jana, K Patra, S Mondal, J Bhat, A Sarkar, P Sengupta, ...Oncotarget 8 (66), 0234, 2017201
11
2017
Understanding the oral absorption of irbesartan using biorelevant dissolution testing and PBPK modeling
N Kaur, PS Thakur, G Shete, R Gangwal, AT Sangamwar, AK BansalAAPS PharmSciTech 21, 1-13, 2020202
10
2020